Love Hemp Group PLC - Directorate Change
RNS Number : 1268I
Love Hemp Group PLC
10 August 2021

10 August 2021

Love Hemp Group PLC

("Love Hemp" or the "Company")


 Directorate Change

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK's leading CBD and Hemp product suppliers, is pleased to announce the appointment of Mr James Ward as a Non-Executive Director of the Company with immediate effect. In conjunction with Mr Ward's appointment, Mr Kevin Ernest is stepping down from his role on the Board effective immediately.

Mr Ward is an accomplished entrepreneurial accountant who sold his professional services business, Whale Rock, to Capita plc (FTSE100) in 2012. He has significant advisory and transaction experience in both public and private markets. Mr Ward's current portfolio of roles includes acting as Independent Non-Executive Director of Visum Technologies plc, H&P Group Ltd, Corporate Modelling Services Ltd & Stanhope Gate Architecture Ltd. He holds a number of advisory roles to technology companies.


Andrew Male, Chairman of Love Hemp Group commented: "I would like to thank Kevin for his support and guidance in helping Love Hemp achieve the success it has to date. We wish him well for his future endeavours.

"I'm delighted to welcome James Ward to the Board of Love Hemp Group. His experience and network in the City and internationally are invaluable for the Company's move to the main market and overall growth strategy."

Save as set out below, there is no further information regarding James Ward that is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.


Current Directorships:

Past Directorships:

Visum Technologies Plc

Stanhope Gate Architecture Limited

Platform Advisory Limited 

Enterprise Improvement Limited incl Corporate Modelling Services Limited, Solvrisk Limited

H&P Group Ltd incl H & P Advisory Limited, H&P Facilities Ltd


Magen David Adom UK

New Whetstone Synagogue Ltd

TES (UK Services) Limited

Rusumo Capital Europe Limited

GerenUK Limited

Dragonfield Investments Limited

UK Over Labs Ltd





For further information please visit: or contact: 


Love Hemp Group

Andrew Male
Chairman & Director


Anna Legge

Chief Communications Officer

+44 (0) 7926 397 675



+44 (0) 7500 773 415


Financial Advisor

Rupert Fane

H&P Advisory Limited


+44 (0) 20 7907 8500


AQSE Corporate Adviser

Mark Anwyl/Allie Feuerlein

Peterhouse Capital Limited


+44 (0) 20 7469 0930

Financial PR

Tim Blythe/Alice McLaren/Madeleine Gordon-Foxwell



+44 (0) 207 138 3204


About Love Hemp Group

Love Hemp Group is one of the UK's leading CBD and Hemp product suppliers. The Company is a pioneer in the UK-based premium high-quality CBD market, with over 40 products including oils, edibles, sprays, cosmetics, topicals and vapes. The Company's range of products are sold online across 70 websites and in over 2,000 stores including some of the biggest retailers in the UK, such as Holland & Barrett, Boots and Ocado. Listed on the Aquis Stock Exchange (AQSE:LIFE) the Company recently changed its name to Love Hemp Group plc, from World High Life,  to better reflect its focus on supporting the "best in class" CBD brand as it embarks on a wider expansion of its core business and offering.


Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.